相关实验视频

Updated: Jul 11, 2025

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate

Published on: September 18, 2013

PRRT2突变对大脑灰质网络的影响,在帕洛克斯性中国原性运动障碍症中

Xiuli Li¹, Du Lei^1,2, Kun Qin¹

¹Department of Radiology, Huaxi MR Research Center (HMRRC), West China Hospital of Sichuan University, No. 37 Guoxue Lane, Wuhou District, Chengdu, 610041, China.

Cerebral cortex (New York, N.Y. : 1991)

|November 13, 2023

概括

富含林的跨膜蛋白2 (PRRT2) 突变会在 Paroxysmal kinesigenic dyskinesia (PKD) 中影响大脑结构. 有PRRT2突变的PKD患者表现出改变的大脑网络,有助于理解疾病机制.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
医疗成像医学成像

背景情况:

富含林的跨膜蛋白2 (PRRT2) 是与 Paroxysmal kinesigenic dyskinesia (PKD) 相关的主要基因.
在PKD患者中,PRRT2突变对大脑结构的特定影响仍然不完全理解.
研究灰色物质形态网络为PKD的神经生物学基础提供了洞察力.

研究的目的:

探索PRRT2突变如何影响PKD个体的灰质形态网络.
分析结构连接体特征,并确定PKD患者子组和健康对照组之间的差异.
评估灰质网络特征在基于PRRT2突变状态的PKD患者分类方面的潜力.

主要方法:

从51名具有PRRT2突变的PKD患者,55名没有PRRT2突变的PKD患者和80名健康对照患者获得结构性MRI数据.
图形理论方法被用来分析基于相似性的灰色物质形态网络和结构连接体特征.
使用支持矢量机 (SVM) 根据灰质网络矩阵对PKD患者进行分类.

主要成果:

与非突变PKD患者和对照组相比,具有PRRT2突变的PKD患者表现出特征性路径长度增加和全球和局部效率降低.
两组PKD患者的右侧后中枢环,右角环和双边丘脑的结节指标相对于对照来说都减少了.
患有PRRT2突变的PKD患者在皮质-基底 - 甲状腺-甲状腺-皮质电路内的节点中心性和结构连接中表现出广泛的减少.

结论:

在PKD患者中,PRRT2突变与灰质形态网络的显著改变有关.
这些网络缺陷,特别是在皮质-基底 - 甲状腺-甲状腺-皮质电路内,可能有助于PKD的病理生理学.
灰质网络分析在将PRRT2-突变的PKD与非突变的PKD分类方面取得了73%的准确性,提供了潜在的诊断见解.

关键词:

这就是PRRT2突变.图形理论中的图形理论.灰色物质的形态网络是灰色物质的形态网络.帕洛克西斯马尔中国性运动障碍症 (paroxysmal kinesigenic dyskinesia) 是一种运动障碍.

更多相关视频

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Assaying the Kinase Activity of LRRK2 in vitro

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...